SHERMAN OAKS, Calif., Feb. 26, 2019 /PRNewswire-PRWeb/ -- SANGUINE BIOSCIENCES, INC. has been awarded a National Science
A majority of clinical trials are delayed or canceled because of insufficient recruitment of eligible participants. This Phase I project seeks to improve the speed, accuracy, and reliability of both clinical trial design and recruitment. Research organizations like pharmaceutical companies and hospitals typically maintain isolated databases with limited, static patient data.
"We are honored to receive this prestigious award by the National Science Foundation. In my experience managing and overseeing research studies both at Sanguine and Stanford, I have found that the biggest delays or bottlenecks are the result of patients' inconvenience in gathering and curating their health data to determine research eligibility, as well as researchers' inconvenience in identifying patients for their studies based on medical record data," said Gerald Lee, Co-Founder and Chief Product Officer at Sanguine. "Our goal is to develop a platform that will enable seamless transactions – patients will be able to provide their data easily, and researchers will be able to search that data and request additional services, easily. This grant will help accelerate that vision by enabling us to add additional expertise to our team that will be instrumental in the development of this technology."
"The National Science Foundation supports small businesses with the most innovative, cutting-edge ideas that have the potential to become great commercial successes and make huge societal impacts," said Barry Johnson, Director of the NSF's Division of Industrial Innovation and Partnerships. "We hope that this seed funding will spark solutions to some of the most important challenges of our time across all areas of science and technology."
Once a small business is awarded a Phase I SBIR/STTR grant (up to $225,000), it becomes eligible to apply for a Phase II grant (up to $750,000). Small businesses with Phase II grants are eligible to receive up to $500,000 in additional matching funds with qualifying third-party investment or sales.
NSF accepts Phase I proposals from small businesses twice annually in June and December. Small businesses with innovative science and technology solutions, and commercial potential are encouraged to apply. All proposals submitted to the NSF SBIR/STTR program undergo a rigorous merit-based review process.
To learn more about America's Seed Fund powered by NSF, visit: https://seedfund.nsf.gov/ About the National Science Foundation's Small Business Programs: America's Seed Fund powered by NSF awards $200 million annually to startups and small businesses, transforming scientific discovery into products and services with commercial and societal impact. Startups working across almost all areas of science and technology can receive up to $1.5 million in non-dilutive funds to support research and development (R&D), helping de-risk technology for commercial success. America's Seed Fund is congressionally mandated through the Small Business Innovation Research (SBIR) program. The NSF is an independent federal agency with a budget of about $7.8 billion that supports fundamental research and education across all fields of science and engineering.
Subscribe to our Free Newsletters!